NLRP3 and lung cancer: Consistently, reduced NLRP3-dependent IL-1β secretion is observed in AMs isolated from the bronchoalveolar lavage of lung cancer patients despite a systemic higher NLRP3 inflammasome activation and IL-1β secretion in peripheral blood leukocytes from these patients [230,231].